Birdwatch Archive

Birdwatch Note Rating

2024-10-08 11:11:03 UTC - SOMEWHAT_HELPFUL

Rated by Participant: 19C99014A287B37E0A1CDAFC8A35C1ED6BD276D5502AE2FCEABBA39B4BB9CE75
Participant Details

Original Note:

The FSA has expressed concern for compounded semaglutide. As of August 31, 2024, they have received 346 reports of adverse affects with it, some requiring hospitalization. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

All Note Details

Original Tweet

All Information

  • noteId - 1843345078687019250
  • participantId -
  • raterParticipantId - 19C99014A287B37E0A1CDAFC8A35C1ED6BD276D5502AE2FCEABBA39B4BB9CE75
  • createdAtMillis - 1728385863850
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - SOMEWHAT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 1
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 184334507868701925019C99014A287B37E0A1CDAFC8A35C1ED6BD276D5502AE2FCEABBA39B4BB9CE75